Related Experiment Video
Updated: Mar 22, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
10.8K
Multiplex SNaPshot-a new simple and efficient CYP2D6 and ADRB1 genotyping method.
Songtao Ben1, Rhonda M Cooper-DeHoff2, Hanna K Flaten3
1Human Medical Genetics Program, University of Colorado, Aurora, CO, 80045, USA.
Human Genomics
|April 25, 2016
Summary
A new multiplex SNaPshot assay accurately genotypes CYP2D6 and ADRB1 variants, including gene duplications. This cost-effective method is suitable for high-throughput clinical trials and pharmacogenetic research.
Area of Science:
- Pharmacogenomics
- Molecular Diagnostics
- Clinical Genetics
Background:
- High-throughput genotyping is crucial for clinical trials but existing methods are expensive or complex.
- Traditional assays often involve multiple enzyme digestions or high costs, limiting their use in large-scale studies.
- There is a need for efficient, reliable, and cost-effective genotyping assays for key pharmacogenes like CYP2D6 and ADRB1.
Purpose of the Study:
- To develop an inexpensive, efficient, and reliable multiplex assay for genotyping CYP2D6 and ADRB1.
- The assay needed to accommodate numerous polymorphisms and gene duplications.
- To validate the performance of the developed assay against established methods.
Main Methods:
- Utilized the multiplex SNaPshot® custom genotype method for CYP2D6 and ADRB1 genotyping.
- Compared the SNaPshot method against reference standards genotyped using Taqman Copy Number Variant Assay and pyrosequencing.
- Determined genotype concordance between the novel method and reference standards.
Main Results:
- Successfully genotyped 119 subjects for CYP2D6 and ADRB1 variants.
- Identified CYP2D6 metabolizer phenotypes: 5.9% poor, 15.1% intermediate, 74.8% extensive, and 4.2% ultra-rapid metabolizers.
- Determined genotype frequencies for ADRB1 variants rs1801253 (Gly389Arg) and rs1801252 (Ser49Gly).
- Achieved high concordance between the multiplex SNaPshot method and reference genotyping results.
Conclusions:
- The multiplex SNaPshot method provides specific and accurate detection of CYP2D6 and ADRB1 genotypes and haplotypes.
- This platform is simple, efficient, and well-suited for high-throughput genotyping in clinical and research settings.
- The developed assay addresses the need for cost-effective and reliable genetic testing in pharmacogenomics.
